The device creates lesions to disrupt nerve signals that drive mucus production.Dive Brief:Neurent Medical has raised 62.5 million euros ($74 million) to commercialize a device that treats a common nasal condition, the company said Wednesday.The Series C financing will equip Neurent to expand commercialization of a product that delivers radiofrequency energy to treat chronic rhinitis […]
